Sarepta Therapeutics Inc (SRPT)

Days of sales outstanding (DSO)

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Receivables turnover		3.70	3.08	3.47	4.24	4.36	4.28	4.35	4.10	4.30	4.59	4.31	4.71	4.85	5.33	4.06	4.33	3.81	4.19	5.37	6.05
DSO	days	98.53	118.32	105.32	86.14	83.74	85.26	83.96	89.09	84.93	79.56	84.69	77.56	75.25	68.49	89.82	84.34	95.73	87.10	68.01	60.36

March 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.70
= 98.53

The Days Sales Outstanding (DSO) for Sarepta Therapeutics Inc has fluctuated over the past few quarters. On Mar 31, 2024, the DSO was 98.53 days, which decreased from the previous quarter at 118.32 days on Dec 31, 2023. This signifies that the company took fewer days to collect its accounts receivable in the most recent quarter.

However, when compared to the same quarter last year, the DSO has increased significantly. For example, on Mar 31, 2023, the DSO was 83.74 days, indicating a deterioration in the company's ability to collect outstanding sales in a timely manner.

Overall, there appears to be some volatility in Sarepta Therapeutics Inc's DSO. It is important for the company to effectively manage its accounts receivable to ensure timely collection and maintain healthy cash flows. Further monitoring of this metric will be crucial to evaluate the company's financial performance and efficiency in managing its working capital.